Global Viral Vector Manufacturing CDMO Services Market Growth (Status and Outlook) 2026-2032

June 2026 | 206 pages | ID: G4E0BE8C970FEN
LP Information

Abstracts

The global Viral Vector Manufacturing CDMO Services market size is predicted to grow from US$ 814 million in 2025 to US$ 3661 million in 2032; it is expected to grow at a CAGR of 24.4% from 2026 to 2032.

Viral Vector Manufacturing CDMO Services refer to providing professional viral vector production and development services to biopharmaceutical companies. These viral vectors are usually used in gene therapy, vaccine development, cell therapy and other fields. CDMO organizations are responsible for the design and optimization of viral vectors to large-scale production in accordance with GMP standards, ensuring the safety and effectiveness of the products, while strictly controlling the quality of each production link. These services provide key technical support for biopharmaceutical companies to help accelerate the development and commercialization of their products.

The Viral Vector Manufacturing CDMO Services market has emerged as a critical enabler of the rapidly growing gene therapy and advanced biologics sector, driven by the increasing demand for specialized production capabilities and accelerated time-to-market for innovative therapies. The market is characterized by high technological barriers, requiring expertise in viral vector design, process development, cGMP-compliant manufacturing, and quality assurance. Companies in this space are leveraging advanced bioprocessing technologies, automation, and artificial intelligence tools to improve yield, consistency, and scalability while maintaining regulatory compliance. Strategic partnerships between biotechnology firms and CDMOs are becoming increasingly common, allowing developers to outsource complex manufacturing tasks and focus on clinical development and commercialization. Overall, the market is marked by intense competition among specialized service providers, rapid technological innovation, and growing adoption of viral vector-based therapies across diverse therapeutic areas, positioning CDMOs as indispensable partners in the biopharmaceutical value chain.

LPI (LP Information)' newest research report, the ?Viral Vector Manufacturing CDMO Services Industry Forecast? looks at past sales and reviews total world Viral Vector Manufacturing CDMO Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Viral Vector Manufacturing CDMO Services sales for 2026 through 2032. With Viral Vector Manufacturing CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Vector Manufacturing CDMO Services industry.

This Insight Report provides a comprehensive analysis of the global Viral Vector Manufacturing CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Vector Manufacturing CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Viral Vector Manufacturing CDMO Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Vector Manufacturing CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Vector Manufacturing CDMO Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vector Manufacturing CDMO Services market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Adeno-associated Virus
• Lentivirus
• Adenovirus
• HSV
• Others

Segmentation by Development Scope:

• Clinical stage CDMOs
• Commercial stage CDMOs
• End to end lifecycle CDMOs

Segmentation by Manufacturing Technology:

• Adherent Cell Based
• Suspension Based

Segmentation by Application:

• Vaccine Development
• Gene Therapy
• Academic Scientific Research Institution
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Thermo Fisher Scientific
• Lonza
• Catalent
• Charles River
• Merck
• SK pharmteco
• Oxford Biomedica
• AGC Biologics?MolMed?
• Gene Universal
• Polyplus (Sartorius)
• CCRM
• FUJIFILM Diosynth Biotechnologies
• Biovian
• Miltenyi Bioindustry
• Aldevron
• Takara Bio
• Yposkesi
• Genezen
• Exthera
• Flash Therapeutics
• VIVEBiotech
• FinVector
• uBriGene
• Eurogentec
• VGXI
• GenScript ProBio
• EurekaBio
• Obio Technology
• GeneSail Biotech
• VectorBuilder
• WuXi ATU
• Ubrigene
• Porton Biologics
• Pharmaron
• PackGene Biotechnology
• Hillgene
• Asymchem

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Viral Vector Manufacturing CDMO Services Market Size (2021-2032)
  2.1.2 Viral Vector Manufacturing CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Viral Vector Manufacturing CDMO Services by Country/Region (2021, 2025 & 2032)
2.2 Viral Vector Manufacturing CDMO Services Segment by Type
  2.2.1 Adeno-associated Virus
  2.2.2 Lentivirus
  2.2.3 Adenovirus
  2.2.4 HSV
  2.2.5 Others
  2.2.6 Viral Vector Manufacturing CDMO Services Market Size by Type
    2.2.6.1 Viral Vector Manufacturing CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.6.2 Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Type (2021-2026)
2.3 Viral Vector Manufacturing CDMO Services Segment by Development Scope
  2.3.1 Clinical stage CDMOs
  2.3.2 Commercial stage CDMOs
  2.3.3 End to end lifecycle CDMOs
  2.3.4 Viral Vector Manufacturing CDMO Services Market Size by Development Scope
    2.3.4.1 Viral Vector Manufacturing CDMO Services Market Size CAGR by Development Scope (2021 VS 2025 VS 2032)
    2.3.4.2 Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Development Scope (2021-2026)
2.4 Viral Vector Manufacturing CDMO Services Segment by Manufacturing Technology
  2.4.1 Adherent Cell Based
  2.4.2 Suspension Based
  2.4.3 Viral Vector Manufacturing CDMO Services Market Size by Manufacturing Technology
    2.4.3.1 Viral Vector Manufacturing CDMO Services Market Size CAGR by Manufacturing Technology (2021 VS 2025 VS 2032)
    2.4.3.2 Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Manufacturing Technology (2021-2026)
2.5 Viral Vector Manufacturing CDMO Services Segment by Application
  2.5.1 Vaccine Development
  2.5.2 Gene Therapy
  2.5.3 Academic Scientific Research Institution
  2.5.4 Others
  2.5.5 Viral Vector Manufacturing CDMO Services Market Size by Application
    2.5.5.1 Viral Vector Manufacturing CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.5.5.2 Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Application (2021-2026)

3 VIRAL VECTOR MANUFACTURING CDMO SERVICES MARKET SIZE BY PLAYER

3.1 Viral Vector Manufacturing CDMO Services Market Size Market Share by Player
  3.1.1 Global Viral Vector Manufacturing CDMO Services Revenue by Player (2021-2026)
  3.1.2 Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Player (2021-2026)
3.2 Global Viral Vector Manufacturing CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 VIRAL VECTOR MANUFACTURING CDMO SERVICES BY REGION

4.1 Viral Vector Manufacturing CDMO Services Market Size by Region (2021-2026)
4.2 Global Viral Vector Manufacturing CDMO Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Viral Vector Manufacturing CDMO Services Market Size Growth (2021-2026)
4.4 APAC Viral Vector Manufacturing CDMO Services Market Size Growth (2021-2026)
4.5 Europe Viral Vector Manufacturing CDMO Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Viral Vector Manufacturing CDMO Services Market Size by Country (2021-2026)
5.2 Americas Viral Vector Manufacturing CDMO Services Market Size by Type (2021-2026)
5.3 Americas Viral Vector Manufacturing CDMO Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Viral Vector Manufacturing CDMO Services Market Size by Region (2021-2026)
6.2 APAC Viral Vector Manufacturing CDMO Services Market Size by Type (2021-2026)
6.3 APAC Viral Vector Manufacturing CDMO Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Viral Vector Manufacturing CDMO Services Market Size by Country (2021-2026)
7.2 Europe Viral Vector Manufacturing CDMO Services Market Size by Type (2021-2026)
7.3 Europe Viral Vector Manufacturing CDMO Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Viral Vector Manufacturing CDMO Services by Region (2021-2026)
8.2 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL VIRAL VECTOR MANUFACTURING CDMO SERVICES MARKET FORECAST

10.1 Global Viral Vector Manufacturing CDMO Services Forecast by Region (2027-2032)
  10.1.1 Global Viral Vector Manufacturing CDMO Services Forecast by Region (2027-2032)
  10.1.2 Americas Viral Vector Manufacturing CDMO Services Forecast
  10.1.3 APAC Viral Vector Manufacturing CDMO Services Forecast
  10.1.4 Europe Viral Vector Manufacturing CDMO Services Forecast
  10.1.5 Middle East & Africa Viral Vector Manufacturing CDMO Services Forecast
10.2 Americas Viral Vector Manufacturing CDMO Services Forecast by Country (2027-2032)
  10.2.1 United States Market Viral Vector Manufacturing CDMO Services Forecast
  10.2.2 Canada Market Viral Vector Manufacturing CDMO Services Forecast
  10.2.3 Mexico Market Viral Vector Manufacturing CDMO Services Forecast
  10.2.4 Brazil Market Viral Vector Manufacturing CDMO Services Forecast
10.3 APAC Viral Vector Manufacturing CDMO Services Forecast by Region (2027-2032)
  10.3.1 China Viral Vector Manufacturing CDMO Services Market Forecast
  10.3.2 Japan Market Viral Vector Manufacturing CDMO Services Forecast
  10.3.3 Korea Market Viral Vector Manufacturing CDMO Services Forecast
  10.3.4 Southeast Asia Market Viral Vector Manufacturing CDMO Services Forecast
  10.3.5 India Market Viral Vector Manufacturing CDMO Services Forecast
  10.3.6 Australia Market Viral Vector Manufacturing CDMO Services Forecast
10.4 Europe Viral Vector Manufacturing CDMO Services Forecast by Country (2027-2032)
  10.4.1 Germany Market Viral Vector Manufacturing CDMO Services Forecast
  10.4.2 France Market Viral Vector Manufacturing CDMO Services Forecast
  10.4.3 UK Market Viral Vector Manufacturing CDMO Services Forecast
  10.4.4 Italy Market Viral Vector Manufacturing CDMO Services Forecast
  10.4.5 Russia Market Viral Vector Manufacturing CDMO Services Forecast
10.5 Middle East & Africa Viral Vector Manufacturing CDMO Services Forecast by Region (2027-2032)
  10.5.1 Egypt Market Viral Vector Manufacturing CDMO Services Forecast
  10.5.2 South Africa Market Viral Vector Manufacturing CDMO Services Forecast
  10.5.3 Israel Market Viral Vector Manufacturing CDMO Services Forecast
  10.5.4 Turkey Market Viral Vector Manufacturing CDMO Services Forecast
10.6 Global Viral Vector Manufacturing CDMO Services Forecast by Type (2027-2032)
10.7 Global Viral Vector Manufacturing CDMO Services Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Viral Vector Manufacturing CDMO Services Forecast

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fisher Scientific
  11.1.1 Thermo Fisher Scientific Company Information
  11.1.2 Thermo Fisher Scientific Viral Vector Manufacturing CDMO Services Product Offered
  11.1.3 Thermo Fisher Scientific Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Thermo Fisher Scientific Main Business Overview
  11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Lonza
  11.2.1 Lonza Company Information
  11.2.2 Lonza Viral Vector Manufacturing CDMO Services Product Offered
  11.2.3 Lonza Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Lonza Main Business Overview
  11.2.5 Lonza Latest Developments
11.3 Catalent
  11.3.1 Catalent Company Information
  11.3.2 Catalent Viral Vector Manufacturing CDMO Services Product Offered
  11.3.3 Catalent Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Catalent Main Business Overview
  11.3.5 Catalent Latest Developments
11.4 Charles River
  11.4.1 Charles River Company Information
  11.4.2 Charles River Viral Vector Manufacturing CDMO Services Product Offered
  11.4.3 Charles River Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Charles River Main Business Overview
  11.4.5 Charles River Latest Developments
11.5 Merck
  11.5.1 Merck Company Information
  11.5.2 Merck Viral Vector Manufacturing CDMO Services Product Offered
  11.5.3 Merck Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Merck Main Business Overview
  11.5.5 Merck Latest Developments
11.6 SK pharmteco
  11.6.1 SK pharmteco Company Information
  11.6.2 SK pharmteco Viral Vector Manufacturing CDMO Services Product Offered
  11.6.3 SK pharmteco Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 SK pharmteco Main Business Overview
  11.6.5 SK pharmteco Latest Developments
11.7 Oxford Biomedica
  11.7.1 Oxford Biomedica Company Information
  11.7.2 Oxford Biomedica Viral Vector Manufacturing CDMO Services Product Offered
  11.7.3 Oxford Biomedica Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Oxford Biomedica Main Business Overview
  11.7.5 Oxford Biomedica Latest Developments
11.8 AGC Biologics(MolMed)
  11.8.1 AGC Biologics(MolMed) Company Information
  11.8.2 AGC Biologics(MolMed) Viral Vector Manufacturing CDMO Services Product Offered
  11.8.3 AGC Biologics(MolMed) Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 AGC Biologics(MolMed) Main Business Overview
  11.8.5 AGC Biologics(MolMed) Latest Developments
11.9 Gene Universal
  11.9.1 Gene Universal Company Information
  11.9.2 Gene Universal Viral Vector Manufacturing CDMO Services Product Offered
  11.9.3 Gene Universal Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Gene Universal Main Business Overview
  11.9.5 Gene Universal Latest Developments
11.10 Polyplus (Sartorius)
  11.10.1 Polyplus (Sartorius) Company Information
  11.10.2 Polyplus (Sartorius) Viral Vector Manufacturing CDMO Services Product Offered
  11.10.3 Polyplus (Sartorius) Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Polyplus (Sartorius) Main Business Overview
  11.10.5 Polyplus (Sartorius) Latest Developments
11.11 CCRM
  11.11.1 CCRM Company Information
  11.11.2 CCRM Viral Vector Manufacturing CDMO Services Product Offered
  11.11.3 CCRM Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 CCRM Main Business Overview
  11.11.5 CCRM Latest Developments
11.12 FUJIFILM Diosynth Biotechnologies
  11.12.1 FUJIFILM Diosynth Biotechnologies Company Information
  11.12.2 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing CDMO Services Product Offered
  11.12.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
  11.12.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.13 Biovian
  11.13.1 Biovian Company Information
  11.13.2 Biovian Viral Vector Manufacturing CDMO Services Product Offered
  11.13.3 Biovian Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Biovian Main Business Overview
  11.13.5 Biovian Latest Developments
11.14 Miltenyi Bioindustry
  11.14.1 Miltenyi Bioindustry Company Information
  11.14.2 Miltenyi Bioindustry Viral Vector Manufacturing CDMO Services Product Offered
  11.14.3 Miltenyi Bioindustry Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 Miltenyi Bioindustry Main Business Overview
  11.14.5 Miltenyi Bioindustry Latest Developments
11.15 Aldevron
  11.15.1 Aldevron Company Information
  11.15.2 Aldevron Viral Vector Manufacturing CDMO Services Product Offered
  11.15.3 Aldevron Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Aldevron Main Business Overview
  11.15.5 Aldevron Latest Developments
11.16 Takara Bio
  11.16.1 Takara Bio Company Information
  11.16.2 Takara Bio Viral Vector Manufacturing CDMO Services Product Offered
  11.16.3 Takara Bio Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 Takara Bio Main Business Overview
  11.16.5 Takara Bio Latest Developments
11.17 Yposkesi
  11.17.1 Yposkesi Company Information
  11.17.2 Yposkesi Viral Vector Manufacturing CDMO Services Product Offered
  11.17.3 Yposkesi Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 Yposkesi Main Business Overview
  11.17.5 Yposkesi Latest Developments
11.18 Genezen
  11.18.1 Genezen Company Information
  11.18.2 Genezen Viral Vector Manufacturing CDMO Services Product Offered
  11.18.3 Genezen Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 Genezen Main Business Overview
  11.18.5 Genezen Latest Developments
11.19 Exthera
  11.19.1 Exthera Company Information
  11.19.2 Exthera Viral Vector Manufacturing CDMO Services Product Offered
  11.19.3 Exthera Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.19.4 Exthera Main Business Overview
  11.19.5 Exthera Latest Developments
11.20 Flash Therapeutics
  11.20.1 Flash Therapeutics Company Information
  11.20.2 Flash Therapeutics Viral Vector Manufacturing CDMO Services Product Offered
  11.20.3 Flash Therapeutics Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.20.4 Flash Therapeutics Main Business Overview
  11.20.5 Flash Therapeutics Latest Developments
11.21 VIVEBiotech
  11.21.1 VIVEBiotech Company Information
  11.21.2 VIVEBiotech Viral Vector Manufacturing CDMO Services Product Offered
  11.21.3 VIVEBiotech Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.21.4 VIVEBiotech Main Business Overview
  11.21.5 VIVEBiotech Latest Developments
11.22 FinVector
  11.22.1 FinVector Company Information
  11.22.2 FinVector Viral Vector Manufacturing CDMO Services Product Offered
  11.22.3 FinVector Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.22.4 FinVector Main Business Overview
  11.22.5 FinVector Latest Developments
11.23 uBriGene
  11.23.1 uBriGene Company Information
  11.23.2 uBriGene Viral Vector Manufacturing CDMO Services Product Offered
  11.23.3 uBriGene Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.23.4 uBriGene Main Business Overview
  11.23.5 uBriGene Latest Developments
11.24 Eurogentec
  11.24.1 Eurogentec Company Information
  11.24.2 Eurogentec Viral Vector Manufacturing CDMO Services Product Offered
  11.24.3 Eurogentec Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.24.4 Eurogentec Main Business Overview
  11.24.5 Eurogentec Latest Developments
11.25 VGXI
  11.25.1 VGXI Company Information
  11.25.2 VGXI Viral Vector Manufacturing CDMO Services Product Offered
  11.25.3 VGXI Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.25.4 VGXI Main Business Overview
  11.25.5 VGXI Latest Developments
11.26 GenScript ProBio
  11.26.1 GenScript ProBio Company Information
  11.26.2 GenScript ProBio Viral Vector Manufacturing CDMO Services Product Offered
  11.26.3 GenScript ProBio Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.26.4 GenScript ProBio Main Business Overview
  11.26.5 GenScript ProBio Latest Developments
11.27 EurekaBio
  11.27.1 EurekaBio Company Information
  11.27.2 EurekaBio Viral Vector Manufacturing CDMO Services Product Offered
  11.27.3 EurekaBio Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.27.4 EurekaBio Main Business Overview
  11.27.5 EurekaBio Latest Developments
11.28 Obio Technology
  11.28.1 Obio Technology Company Information
  11.28.2 Obio Technology Viral Vector Manufacturing CDMO Services Product Offered
  11.28.3 Obio Technology Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.28.4 Obio Technology Main Business Overview
  11.28.5 Obio Technology Latest Developments
11.29 GeneSail Biotech
  11.29.1 GeneSail Biotech Company Information
  11.29.2 GeneSail Biotech Viral Vector Manufacturing CDMO Services Product Offered
  11.29.3 GeneSail Biotech Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.29.4 GeneSail Biotech Main Business Overview
  11.29.5 GeneSail Biotech Latest Developments
11.30 VectorBuilder
  11.30.1 VectorBuilder Company Information
  11.30.2 VectorBuilder Viral Vector Manufacturing CDMO Services Product Offered
  11.30.3 VectorBuilder Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.30.4 VectorBuilder Main Business Overview
  11.30.5 VectorBuilder Latest Developments
11.31 WuXi ATU
  11.31.1 WuXi ATU Company Information
  11.31.2 WuXi ATU Viral Vector Manufacturing CDMO Services Product Offered
  11.31.3 WuXi ATU Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.31.4 WuXi ATU Main Business Overview
  11.31.5 WuXi ATU Latest Developments
11.32 Ubrigene
  11.32.1 Ubrigene Company Information
  11.32.2 Ubrigene Viral Vector Manufacturing CDMO Services Product Offered
  11.32.3 Ubrigene Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.32.4 Ubrigene Main Business Overview
  11.32.5 Ubrigene Latest Developments
11.33 Porton Biologics
  11.33.1 Porton Biologics Company Information
  11.33.2 Porton Biologics Viral Vector Manufacturing CDMO Services Product Offered
  11.33.3 Porton Biologics Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.33.4 Porton Biologics Main Business Overview
  11.33.5 Porton Biologics Latest Developments
11.34 Pharmaron
  11.34.1 Pharmaron Company Information
  11.34.2 Pharmaron Viral Vector Manufacturing CDMO Services Product Offered
  11.34.3 Pharmaron Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.34.4 Pharmaron Main Business Overview
  11.34.5 Pharmaron Latest Developments
11.35 PackGene Biotechnology
  11.35.1 PackGene Biotechnology Company Information
  11.35.2 PackGene Biotechnology Viral Vector Manufacturing CDMO Services Product Offered
  11.35.3 PackGene Biotechnology Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.35.4 PackGene Biotechnology Main Business Overview
  11.35.5 PackGene Biotechnology Latest Developments
11.36 Hillgene
  11.36.1 Hillgene Company Information
  11.36.2 Hillgene Viral Vector Manufacturing CDMO Services Product Offered
  11.36.3 Hillgene Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.36.4 Hillgene Main Business Overview
  11.36.5 Hillgene Latest Developments
11.37 Asymchem
  11.37.1 Asymchem Company Information
  11.37.2 Asymchem Viral Vector Manufacturing CDMO Services Product Offered
  11.37.3 Asymchem Viral Vector Manufacturing CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
  11.37.4 Asymchem Main Business Overview
  11.37.5 Asymchem Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Viral Vector Manufacturing CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Viral Vector Manufacturing CDMO Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Adeno-associated Virus
Table 4. Major Players of Lentivirus
Table 5. Major Players of Adenovirus
Table 6. Major Players of HSV
Table 7. Major Players of Others
Table 8. Viral Vector Manufacturing CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Viral Vector Manufacturing CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Type (2021-2026)
Table 11. Major Players of Clinical stage CDMOs
Table 12. Major Players of Commercial stage CDMOs
Table 13. Major Players of End to end lifecycle CDMOs
Table 14. Viral Vector Manufacturing CDMO Services Market Size CAGR by Development Scope (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global Viral Vector Manufacturing CDMO Services Market Size by Development Scope (2021-2026) & ($ millions)
Table 16. Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Development Scope (2021-2026)
Table 17. Major Players of Adherent Cell Based
Table 18. Major Players of Suspension Based
Table 19. Viral Vector Manufacturing CDMO Services Market Size CAGR by Manufacturing Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Viral Vector Manufacturing CDMO Services Market Size by Manufacturing Technology (2021-2026) & ($ millions)
Table 21. Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Manufacturing Technology (2021-2026)
Table 22. Viral Vector Manufacturing CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Viral Vector Manufacturing CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Application (2021-2026)
Table 25. Global Viral Vector Manufacturing CDMO Services Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Player (2021-2026)
Table 27. Viral Vector Manufacturing CDMO Services Key Players Head office and Products Offered
Table 28. Viral Vector Manufacturing CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Viral Vector Manufacturing CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Region (2021-2026)
Table 33. Global Viral Vector Manufacturing CDMO Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Viral Vector Manufacturing CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Viral Vector Manufacturing CDMO Services Market Size Market Share by Country (2021-2026)
Table 37. Americas Viral Vector Manufacturing CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Viral Vector Manufacturing CDMO Services Market Size Market Share by Type (2021-2026)
Table 39. Americas Viral Vector Manufacturing CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Viral Vector Manufacturing CDMO Services Market Size Market Share by Application (2021-2026)
Table 41. APAC Viral Vector Manufacturing CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Viral Vector Manufacturing CDMO Services Market Size Market Share by Region (2021-2026)
Table 43. APAC Viral Vector Manufacturing CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Viral Vector Manufacturing CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Viral Vector Manufacturing CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Viral Vector Manufacturing CDMO Services Market Size Market Share by Country (2021-2026)
Table 47. Europe Viral Vector Manufacturing CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Viral Vector Manufacturing CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Viral Vector Manufacturing CDMO Services
Table 53. Key Market Challenges & Risks of Viral Vector Manufacturing CDMO Services
Table 54. Key Industry Trends of Viral Vector Manufacturing CDMO Services
Table 55. Global Viral Vector Manufacturing CDMO Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Viral Vector Manufacturing CDMO Services Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Viral Vector Manufacturing CDMO Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Viral Vector Manufacturing CDMO Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Thermo Fisher Scientific Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 60. Thermo Fisher Scientific Viral Vector Manufacturing CDMO Services Product Offered
Table 61. Thermo Fisher Scientific Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Thermo Fisher Scientific Main Business
Table 63. Thermo Fisher Scientific Latest Developments
Table 64. Lonza Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 65. Lonza Viral Vector Manufacturing CDMO Services Product Offered
Table 66. Lonza Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Lonza Main Business
Table 68. Lonza Latest Developments
Table 69. Catalent Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 70. Catalent Viral Vector Manufacturing CDMO Services Product Offered
Table 71. Catalent Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Catalent Main Business
Table 73. Catalent Latest Developments
Table 74. Charles River Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 75. Charles River Viral Vector Manufacturing CDMO Services Product Offered
Table 76. Charles River Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Charles River Main Business
Table 78. Charles River Latest Developments
Table 79. Merck Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 80. Merck Viral Vector Manufacturing CDMO Services Product Offered
Table 81. Merck Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. SK pharmteco Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 85. SK pharmteco Viral Vector Manufacturing CDMO Services Product Offered
Table 86. SK pharmteco Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. SK pharmteco Main Business
Table 88. SK pharmteco Latest Developments
Table 89. Oxford Biomedica Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 90. Oxford Biomedica Viral Vector Manufacturing CDMO Services Product Offered
Table 91. Oxford Biomedica Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Oxford Biomedica Main Business
Table 93. Oxford Biomedica Latest Developments
Table 94. AGC Biologics?MolMed? Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 95. AGC Biologics?MolMed? Viral Vector Manufacturing CDMO Services Product Offered
Table 96. AGC Biologics?MolMed? Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. AGC Biologics?MolMed? Main Business
Table 98. AGC Biologics?MolMed? Latest Developments
Table 99. Gene Universal Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 100. Gene Universal Viral Vector Manufacturing CDMO Services Product Offered
Table 101. Gene Universal Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Gene Universal Main Business
Table 103. Gene Universal Latest Developments
Table 104. Polyplus (Sartorius) Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 105. Polyplus (Sartorius) Viral Vector Manufacturing CDMO Services Product Offered
Table 106. Polyplus (Sartorius) Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Polyplus (Sartorius) Main Business
Table 108. Polyplus (Sartorius) Latest Developments
Table 109. CCRM Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 110. CCRM Viral Vector Manufacturing CDMO Services Product Offered
Table 111. CCRM Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. CCRM Main Business
Table 113. CCRM Latest Developments
Table 114. FUJIFILM Diosynth Biotechnologies Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 115. FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing CDMO Services Product Offered
Table 116. FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. FUJIFILM Diosynth Biotechnologies Main Business
Table 118. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 119. Biovian Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 120. Biovian Viral Vector Manufacturing CDMO Services Product Offered
Table 121. Biovian Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Biovian Main Business
Table 123. Biovian Latest Developments
Table 124. Miltenyi Bioindustry Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 125. Miltenyi Bioindustry Viral Vector Manufacturing CDMO Services Product Offered
Table 126. Miltenyi Bioindustry Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Miltenyi Bioindustry Main Business
Table 128. Miltenyi Bioindustry Latest Developments
Table 129. Aldevron Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 130. Aldevron Viral Vector Manufacturing CDMO Services Product Offered
Table 131. Aldevron Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Aldevron Main Business
Table 133. Aldevron Latest Developments
Table 134. Takara Bio Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 135. Takara Bio Viral Vector Manufacturing CDMO Services Product Offered
Table 136. Takara Bio Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Takara Bio Main Business
Table 138. Takara Bio Latest Developments
Table 139. Yposkesi Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 140. Yposkesi Viral Vector Manufacturing CDMO Services Product Offered
Table 141. Yposkesi Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Yposkesi Main Business
Table 143. Yposkesi Latest Developments
Table 144. Genezen Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 145. Genezen Viral Vector Manufacturing CDMO Services Product Offered
Table 146. Genezen Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Genezen Main Business
Table 148. Genezen Latest Developments
Table 149. Exthera Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 150. Exthera Viral Vector Manufacturing CDMO Services Product Offered
Table 151. Exthera Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Exthera Main Business
Table 153. Exthera Latest Developments
Table 154. Flash Therapeutics Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 155. Flash Therapeutics Viral Vector Manufacturing CDMO Services Product Offered
Table 156. Flash Therapeutics Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. Flash Therapeutics Main Business
Table 158. Flash Therapeutics Latest Developments
Table 159. VIVEBiotech Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 160. VIVEBiotech Viral Vector Manufacturing CDMO Services Product Offered
Table 161. VIVEBiotech Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 162. VIVEBiotech Main Business
Table 163. VIVEBiotech Latest Developments
Table 164. FinVector Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 165. FinVector Viral Vector Manufacturing CDMO Services Product Offered
Table 166. FinVector Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 167. FinVector Main Business
Table 168. FinVector Latest Developments
Table 169. uBriGene Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 170. uBriGene Viral Vector Manufacturing CDMO Services Product Offered
Table 171. uBriGene Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 172. uBriGene Main Business
Table 173. uBriGene Latest Developments
Table 174. Eurogentec Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 175. Eurogentec Viral Vector Manufacturing CDMO Services Product Offered
Table 176. Eurogentec Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 177. Eurogentec Main Business
Table 178. Eurogentec Latest Developments
Table 179. VGXI Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 180. VGXI Viral Vector Manufacturing CDMO Services Product Offered
Table 181. VGXI Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 182. VGXI Main Business
Table 183. VGXI Latest Developments
Table 184. GenScript ProBio Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 185. GenScript ProBio Viral Vector Manufacturing CDMO Services Product Offered
Table 186. GenScript ProBio Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 187. GenScript ProBio Main Business
Table 188. GenScript ProBio Latest Developments
Table 189. EurekaBio Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 190. EurekaBio Viral Vector Manufacturing CDMO Services Product Offered
Table 191. EurekaBio Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 192. EurekaBio Main Business
Table 193. EurekaBio Latest Developments
Table 194. Obio Technology Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 195. Obio Technology Viral Vector Manufacturing CDMO Services Product Offered
Table 196. Obio Technology Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 197. Obio Technology Main Business
Table 198. Obio Technology Latest Developments
Table 199. GeneSail Biotech Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 200. GeneSail Biotech Viral Vector Manufacturing CDMO Services Product Offered
Table 201. GeneSail Biotech Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 202. GeneSail Biotech Main Business
Table 203. GeneSail Biotech Latest Developments
Table 204. VectorBuilder Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 205. VectorBuilder Viral Vector Manufacturing CDMO Services Product Offered
Table 206. VectorBuilder Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 207. VectorBuilder Main Business
Table 208. VectorBuilder Latest Developments
Table 209. WuXi ATU Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 210. WuXi ATU Viral Vector Manufacturing CDMO Services Product Offered
Table 211. WuXi ATU Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 212. WuXi ATU Main Business
Table 213. WuXi ATU Latest Developments
Table 214. Ubrigene Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 215. Ubrigene Viral Vector Manufacturing CDMO Services Product Offered
Table 216. Ubrigene Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 217. Ubrigene Main Business
Table 218. Ubrigene Latest Developments
Table 219. Porton Biologics Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 220. Porton Biologics Viral Vector Manufacturing CDMO Services Product Offered
Table 221. Porton Biologics Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 222. Porton Biologics Main Business
Table 223. Porton Biologics Latest Developments
Table 224. Pharmaron Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 225. Pharmaron Viral Vector Manufacturing CDMO Services Product Offered
Table 226. Pharmaron Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 227. Pharmaron Main Business
Table 228. Pharmaron Latest Developments
Table 229. PackGene Biotechnology Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 230. PackGene Biotechnology Viral Vector Manufacturing CDMO Services Product Offered
Table 231. PackGene Biotechnology Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 232. PackGene Biotechnology Main Business
Table 233. PackGene Biotechnology Latest Developments
Table 234. Hillgene Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 235. Hillgene Viral Vector Manufacturing CDMO Services Product Offered
Table 236. Hillgene Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 237. Hillgene Main Business
Table 238. Hillgene Latest Developments
Table 239. Asymchem Details, Company Type, Viral Vector Manufacturing CDMO Services Area Served and Its Competitors
Table 240. Asymchem Viral Vector Manufacturing CDMO Services Product Offered
Table 241. Asymchem Viral Vector Manufacturing CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 242. Asymchem Main Business
Table 243. Asymchem Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Viral Vector Manufacturing CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Vector Manufacturing CDMO Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Viral Vector Manufacturing CDMO Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Viral Vector Manufacturing CDMO Services Sales Market Share by Country/Region (2025)
Figure 8. Viral Vector Manufacturing CDMO Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Type in 2025
Figure 10. Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Development Scope in 2025
Figure 11. Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Manufacturing Technology in 2025
Figure 12. Viral Vector Manufacturing CDMO Services in Vaccine Development
Figure 13. Global Viral Vector Manufacturing CDMO Services Market: Vaccine Development (2021-2026) & ($ millions)
Figure 14. Viral Vector Manufacturing CDMO Services in Gene Therapy
Figure 15. Global Viral Vector Manufacturing CDMO Services Market: Gene Therapy (2021-2026) & ($ millions)
Figure 16. Viral Vector Manufacturing CDMO Services in Academic Scientific Research Institution
Figure 17. Global Viral Vector Manufacturing CDMO Services Market: Academic Scientific Research Institution (2021-2026) & ($ millions)
Figure 18. Viral Vector Manufacturing CDMO Services in Others
Figure 19. Global Viral Vector Manufacturing CDMO Services Market: Others (2021-2026) & ($ millions)
Figure 20. Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Application in 2025
Figure 21. Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Player in 2025
Figure 22. Global Viral Vector Manufacturing CDMO Services Market Size Market Share by Region (2021-2026)
Figure 23. Americas Viral Vector Manufacturing CDMO Services Market Size 2021-2026 ($ millions)
Figure 24. APAC Viral Vector Manufacturing CDMO Services Market Size 2021-2026 ($ millions)
Figure 25. Europe Viral Vector Manufacturing CDMO Services Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size 2021-2026 ($ millions)
Figure 27. Americas Viral Vector Manufacturing CDMO Services Value Market Share by Country in 2025
Figure 28. United States Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Viral Vector Manufacturing CDMO Services Market Size Market Share by Region in 2025
Figure 33. APAC Viral Vector Manufacturing CDMO Services Market Size Market Share by Type (2021-2026)
Figure 34. APAC Viral Vector Manufacturing CDMO Services Market Size Market Share by Application (2021-2026)
Figure 35. China Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 39. India Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Viral Vector Manufacturing CDMO Services Market Size Market Share by Country in 2025
Figure 42. Europe Viral Vector Manufacturing CDMO Services Market Size Market Share by Type (2021-2026)
Figure 43. Europe Viral Vector Manufacturing CDMO Services Market Size Market Share by Application (2021-2026)
Figure 44. Germany Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 45. France Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Viral Vector Manufacturing CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 58. APAC Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 59. Europe Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 61. United States Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 62. Canada Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 63. Mexico Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 64. Brazil Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 65. China Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 66. Japan Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 67. Korea Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 69. India Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 70. Australia Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 71. Germany Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 72. France Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 73. UK Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 74. Italy Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 75. Russia Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 76. Egypt Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 77. South Africa Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 78. Israel Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 79. Turkey Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)
Figure 80. Global Viral Vector Manufacturing CDMO Services Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Viral Vector Manufacturing CDMO Services Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Viral Vector Manufacturing CDMO Services Market Size 2027-2032 ($ millions)